Skip to content

ExoDoF: Robotic Exoskeleton for Upper Limb Motor Rehabilitation After Stroke

ExoDoF: Robotic Exoskeleton for Upper Limb Motor Rehabilitation After Stroke

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06496529
Enrollment
44
Registered
2024-07-11
Start date
2025-03-01
Completion date
2026-11-30
Last updated
2025-12-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Keywords

stroke recovery, motor recovery, upper extremity recovery

Brief summary

Two decades ago, the projection of recovery of the upper extremity (UE) after a stroke had a very poor prognosis worldwide. Nowadays, thanks to medical advances and early rehabilitation, the prognosis for recovery has improved; however, there is still a limit that no therapy has been able to overcome, related to spontaneous recovery as part of the natural evolution of the pathophysiological process, rather than with the contribution of rehabilitation. Additionally, existing therapies show partial effectiveness on the recovery of UE function, but do not avoid the use of compensatory strategies or alternatives to normal movement. Given this situation, there is an active search for new therapeutic approaches. In this clinical trial the investigators propose a rehabilitation paradigm that promotes the recovery of control of specific planes of movement through the selective restriction of degrees of freedom, simplifying control demands. The investigators sought to test the hypothesis that people with stroke in the early subacute stage and who present alterations in the movement of the upper extremity, a rehabilitation protocol that reduces the degrees of freedom of the UE and trunk, enables greater recovery of the movement of the UE and less use of compensatory movements compared to a protocol without DoF control. The general objective is to demonstrate the effect of training with restriction of the degrees of freedom of UE and trunk, mediated by an exoskeleton and videogames, on the control of the UE.

Interventions

BEHAVIORALDoF intervention

Training of specific uniarticular and single plane movement of the upper limb through an exoskeleton and videogames that will be supervised by a physiotherapist.

Training of multiarticular upper limb movements (vertical, horizontal and diagonal) through videogames and also training of functional task (raise and lower your hand on the table, cleaning a table, put cream on the non-paretic arm, hold a bottle, put a piece of bread or something similar in your mouth, wash your face, brush your hair, store items in a basket, brush teeth, wrote and serve water in glass). This activities will be supervised by a physiotherapist.

Sponsors

Agencia Nacional de Investigación y Desarrollo
CollaboratorOTHER
University of Chile
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 81 Years
Healthy volunteers
No

Inclusion criteria

* Diagnosis of ischemic or hemorrhagic stroke with zero to twelve weeks of evolution. * Subjects with alterations in active voluntary movement of ES with Fugl Meyer less than or equal to 50 points. Strength of shoulder abduction and finger extension from palpable contraction (1 in Medical Research Council (MRC) scale for muscle strength).

Exclusion criteria

* Cognitive impairment that prevents signing the informed consent, following the instructions and understanding the procedures. (MOCA \< 18). * Inability to perform activities sitting for more than 90 minutes or inability to perform activities without severe pain (VAS \> 6) or having limited reach ranges. * Have severe visual impairment that does not allow to carry out the activities associated with the task. * Previous stroke with neurological sequelae in the upper extremity. * Present bilateral sensorimotor alterations. * Damage to the cerebellum/peduncles described in the radiological report or classic signs of cerebellar damage (Upper extremity SARA items of 2 or more)

Design outcomes

Primary

MeasureTime frameDescription
Change in UE-FMA at the end of the training3 days post trainingDifferences between the Upper Extremity Fugl-Meyer Assessment (UE-FMA) at the beginning of the recruitment and at the end of the training
Change in UE-FMA at 6 months post stroke180 days post strokeDifferences between the Upper Extremity Fugl-Meyer Assessment (UE-FMA) at the beginning of the recruitment and at 6 months post stroke

Secondary

MeasureTime frameDescription
Change in iCoh at the end of the training3 days post trainingDifferences between EEG Ipsi-Contralateral Motor Cortex connectivity (iCoh) at the beginning of the training and at the end of the training
Change in iCoh connectivity at 6 months post stroke180 days post strokeDifferences between EEG Ipsi-Contralateral Motor Cortex connectivity (iCoh) at the beginning of the training and at 6 months post stroke
Change in ARAT at 6 months post stroke180 days post strokeDifferences between the Action Research Arm Test (ARAT) at the beginning of the recruitment and at 6 months post stroke
Change in arm kinematics at 6 months post stroke180 days post strokeDifferences between arm kinematics (shoulder, elbow, wrist and finger angles during reaching and grasping a glass) at the beginning of the training and at 6 months post stroke
Change in arm kinematics at the end of the training3 days post trainingDifferences between arm kinematics (shoulder, elbow, wrist and finger angles during reaching and grasping a glass) at the beginning of the training and at the end of the training
Change in ARAT at the end of the training3 days post trainingDifferences between the Action Research Arm Test (ARAT) at the beginning of the recruitment and at the end of the training

Countries

Chile

Contacts

Primary ContactPablo Burgos, PhD
pburgos@uchile.cl19713314101
Backup ContactJuan José Mariman, PhD
juan.mariman@umce.cl+56981928168

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026